Why don't companies want to list in London anymore? Why is this damaging for all of us? How much will it cost the Treasury in lost tax if companies follow AstraZeneca's example and list in the US? Robert and Steph discuss the LSE's fall out of the top 20 world markets for companies that raise money…
